Kathy didn’t win her fight against cancer but, with your help, others will.
- Cancer and cell biology
- Cancer epigenetics
- Cell Signalling
- Laboratory for cancer medicine
- Iron Metabolism
- Liver Disease and Carcinogenesis
- Systems Biology and Genomics
- Targeted drug delivery, imaging and therapy
- Vascular Biology and Stromal Targeting
- Translational Cancer Research
- Clinical science
- Bioimaging Research and Innovation for Translational Engineering
- Centre for Clinical Research in Emergency Medicine
- Translational renal research
- Vascular Engineering
- Molecular medicine
- Brain Growth and Disease
- Epigenetics and genomics
- Mitochondrial Medicine & Biology
- Molecular Endocrinology and Pharmacology
- Neurogenetic Diseases
- Synthetic Biology & Drug Discovery
- Cancer and cell biology
- Research centres
- Research facilities
- Clinical trials
- Laboratory Heads
Synthetic biology and drug discovery
Student project opportunities
Using synthetic biology to create new therapeutics
Research area: Synthetic biology
Chief supervisor: Associate Professor Oliver Rackham
Project suitable for: Honours, Masters and PhD
Essential qualifications: BSc in Biochemistry, Genetics, Microbiology or similar.
Start date: flexible
The rise of antibiotic resistant bacteria, resistance to cancer chemotherapy and the many orphan genetic diseases without any current therapies are creating an increasing burden on our health system and a tragic personal cost to society. Current approaches to discover new medicines, such as high throughput screening of synthetic and natural product libraries, are proving to be increasing ineffective and there is a pressing need for new approaches to discover the next generation of therapeutics. The burgeoning new field of synthetic biology focuses on programming molecules and cells with new and improved functions – using them like Lego blocks. Our team works to harness the tremendous potential of synthetic biology to create new therapeutics for diseases that are resistant to current drugs and for orphan diseases.
(1) Building designer RNA-binding proteins as protein-based gene therapies;
(2) Hijacking cells to developing new antibiotics to address the rise of "superbugs";
(3) Manipulating cellular gene expression to better understand how it can become defective in cancer and to provide new therapeutic approaches.
Associate Professor Oliver Rackham - firstname.lastname@example.org
Coquille S, Filipovska A, Chia T, Rajappa L, Lingford JP, Razif MF, Thore S, Rackham O. (2014) Nature Communications 5:5729.
Filipovska A, Razif MF, Nygård KK, Rackham O. (2011) Nature Chemical Biology 7(7): 425-427.